Literature DB >> 8756422

Reduction of calcium currents by Lambert-Eaton syndrome sera: motoneurons are preferentially affected, and L-type currents are spared.

K D García1, K G Beam.   

Abstract

Previous work has demonstrated that Lambert-Eaton syndrome (LES) antibodies reduce calcium currents in nonneuronal cells and neurons and reduce the amplitude of extracellularly recorded currents at mouse motor nerve terminals. We compared effects of LES sera on whole-cell currents of cultured nerve and muscle. LES sera more strongly reduced calcium currents in motoneurons than in sensory neurons. Motoneuronal potassium currents were unaffected. The sera minimally affected calcium currents in skeletal and cardiac muscle. In motoneurons, both low voltage-activated (LVA) and high voltage-activated (HVA) components of calcium current were decreased, demonstrating that the sera targeted more than one calcium channel type. The HVA current remaining in LES-treated motoneurons was little affected by micromolar omega-conotoxin MVIIC but was reduced > 70% by micromolar nimodipine. This pharmacological profile contrasts with untreated cells and suggest that LES sera primarily spare L-type currents in motoneurons.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8756422      PMCID: PMC6579308     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  65 in total

1.  Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors.

Authors:  L M EATON; E H LAMBERT
Journal:  J Am Med Assoc       Date:  1957-03-30

2.  The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen.

Authors:  C Leveque; T Hoshino; P David; Y Shoji-Kasai; K Leys; A Omori; B Lang; O el Far; K Sato; N Martin-Moutot
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

3.  Selective effects of skeletal muscle extract fractions on motoneuron development in vitro.

Authors:  R G Smith; K Vaca; J McManaman; S H Appel
Journal:  J Neurosci       Date:  1986-02       Impact factor: 6.167

4.  Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation.

Authors:  A Nagel; A G Engel; B Lang; J Newsom-Davis; T Fukuoka
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

5.  omega-Conotoxin GVIA binds to and blocks rat neuromuscular junction.

Authors:  G Rossoni; F Berti; L La Maestra; F Clementi
Journal:  Neurosci Lett       Date:  1994-08-01       Impact factor: 3.046

Review 6.  Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins.

Authors:  B M Olivera; G P Miljanich; J Ramachandran; M E Adams
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

7.  Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome.

Authors:  D O Smith; M W Conklin; P J Jensen; W D Atchison
Journal:  J Physiol       Date:  1995-08-15       Impact factor: 5.182

8.  Adenosine acting at an A1 receptor decreases N-type calcium current in mouse motoneurons.

Authors:  M Mynlieff; K G Beam
Journal:  J Neurosci       Date:  1994-06       Impact factor: 6.167

9.  Differential blockade of voltage-sensitive calcium channels at the mouse neuromuscular junction by novel omega-conopeptides and omega-agatoxin-IVA.

Authors:  S S Bowersox; G P Miljanich; Y Sugiura; C Li; L Nadasdi; B B Hoffman; J Ramachandran; C P Ko
Journal:  J Pharmacol Exp Ther       Date:  1995-04       Impact factor: 4.030

10.  Studies of human myasthenia gravis: electrophysiological and ultrastructural evidence compatible with antibody attachment to acetylcholine receptor complex.

Authors:  J E Rash; E X Albuquerque; C S Hudson; R F Mayer; J R Satterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

View more
  8 in total

1.  Lambert-Eaton antibodies inhibit Ca2+ currents but paradoxically increase exocytosis during stimulus trains in bovine adrenal chromaffin cells.

Authors:  K L Engisch; M M Rich; N Cook; M C Nowycky
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

2.  Lambert-Eaton syndrome antibodies inhibit acetylcholine release and P/Q-type Ca2+ channels in electric ray nerve endings.

Authors:  Y Satoh; N Hirashima; H Tokumaru; M P Takahashi; J Kang; M P Viglione; Y I Kim; Y Kirino
Journal:  J Physiol       Date:  1998-04-15       Impact factor: 5.182

3.  Calcium channel subtypes contributing to acetylcholine release from normal, 4-aminopyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions.

Authors:  F Giovannini; E Sher; R Webster; J Boot; B Lang
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

4.  Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.

Authors:  Michael T Flink; William D Atchison
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

Review 5.  Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.

Authors:  Michael T Flink; William D Atchison
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

6.  The sodium channel Scn8a is the major contributor to the postnatal developmental increase of sodium current density in spinal motoneurons.

Authors:  K D García; L K Sprunger; M H Meisler; K G Beam
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

7.  Tetanic depression is overcome by tonic adenosine A(2A) receptor facilitation of L-type Ca(2+) influx into rat motor nerve terminals.

Authors:  Laura Oliveira; M Alexandrina Timóteo; Paulo Correia-de-Sá
Journal:  J Physiol       Date:  2004-08-05       Impact factor: 5.182

8.  A mutation in CaV2.1 linked to a severe neurodevelopmental disorder impairs channel gating.

Authors:  Sidharth Tyagi; Tyler R Bendrick; Dilyana Filipova; Symeon Papadopoulos; Roger A Bannister
Journal:  J Gen Physiol       Date:  2019-04-23       Impact factor: 4.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.